ERBB2 and breast carcinoma: The American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP) have collaboratively laid down guidelines and algorithms for the evaluation of HER2 protein expression by IHC assay of the invasive component of breast cancer specimens (Figure 2).